Randomised trials of endovascular treatment of stroke are needed

Lancet Neurol. 2010 Jan;9(1):30; author reply 31-2. doi: 10.1016/S1474-4422(09)70349-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acute Disease
  • Brain / blood supply
  • Brain / pathology
  • Cerebrovascular Circulation
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Injections, Intra-Arterial
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Stroke / diagnosis
  • Stroke / drug therapy*
  • Stroke / pathology
  • Thrombolytic Therapy / methods*
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage*
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator